Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Safety and Efficacy of Switching to Alternative Biologics Following Secukinumab Treatment Failure in Patients with Moderate-to-Severe Plaque Psoriasis: A Retrospective Cohort Analysis

  • By

  • Zhongyu Zhang

  • Bin Zhang

  • Yating Wen

  • Qian Hu

  • Wenjun Jiang

  • Jia Zhuo

  • Guangying Luo

  • Yuyi Wang

  • July 6, 2026

Share

Original Source(s)

Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study

  • by Zhongyu Zhang, Bin Zhang, Yating Wen, Qian Hu, Wenjun Jiang, Jia Zhuo, Guangying Luo, Yuyi Wang

  • July 6, 2026

Related Content

Informatics-Based Psychotherapeutic and Psychiatric Interventions in Dermatology: Scoping Review of Impacts on Skin Disease Severity and Mental Health Outcomes

Errors in Table 2

  • July 1, 2026

Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b